What is new in perinatal HIV prevention?
Related Experiment Video
Updated: Feb 15, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Mary G Fowler1, Patricia Flynn2, Jim Aizire3
1Department of Pathology, Johns Hopkins U. School of Medicine, Baltimore, Maryland.
Insights
New antiretroviral therapy (ART) regimens show promise in preventing pediatric HIV infections among breastfeeding mothers. However, optimizing safety and adherence remains crucial for achieving the global elimination of new pediatric HIV cases.
Area of Science:
- Clinical trials
- HIV research
- Pediatric infectious diseases
Background:
- HIV continues to pose a significant threat to pediatric populations globally.
- Preventing mother-to-child transmission (PMTCT) of HIV is a critical public health goal.
- Antiretroviral therapy (ART) plays a vital role in managing HIV in pregnant and breastfeeding women.
Purpose of the Study:
- To review recent clinical trial, laboratory, and observational findings on pediatric HIV prevention.
- To highlight progress and safety concerns of antiretroviral regimens in HIV-infected breastfeeding women.
- To address adherence challenges for HIV-infected mothers on ART.
Main Methods:
- Review of international clinical trial data, including the IMPAACT PROMISE trial.
- Analysis of laboratory and observational findings related to PMTCT.
- Examination of safety and efficacy data for current and emerging ART regimens.
Main Results:
- Steady progress has been made in reducing pediatric HIV transmission worldwide.
- Current ART regimens demonstrate efficacy but present safety concerns.
- Maternal adherence to daily ART remains a significant challenge.
Conclusions:
- Virtual elimination of pediatric HIV requires optimizing the safety of new ART regimens.
- Future strategies must consider regimens with reduced dependence on daily maternal adherence.
- Addressing specific toxicities and improving adherence are key to achieving global pediatric HIV elimination.
Purpose Of Review:
The purpose of this review is to describe recent clinical trial, laboratory and observational findings that highlight both the progress that can be achieved in elimination of new pediatric infections in international clinical trial settings among HIV-infected breastfeeding women while also describing recent safety concerns related to currently used antiretroviral regimens. The article will also address the ongoing adherence challenges for HIV-infected mothers in taking their antiretroviral drugs. This information is timely and relevant as new regimens are being considered for both prevention of mother-to-child transmission (PMTCT) of HIV and HIV treatment options worldwide.
Recent Findings:
The main themes described in this article include both efficacy of different antiretroviral therapy (ART) regimens currently being rolled out internationally for PMTCT as well as safety findings from recent research including a large multisite international trial, PROMISE.
Summary:
The findings from the IMPAACT PROMISE trial as well as other recent trial and observational findings suggest that while progress has been steady in reducing PMTCT worldwide, the goal of virtual elimination of pediatric HIV worldwide will require careful attention to optimizing safety of new regimens which are less dependent on maternal daily ART adherence and safer in preventing certain toxicities.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Models of Health Promotion and Illness Prevention II
The agent-host-environment model states that disease results...

